Leonard Lewis, DO
Family Medicine · Grand Rapids, MINPI 1174581300
Payments from drug & device makers
Across 358 payments — averaging $16.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Novo Nordisk$1K
- Pfizer$628
- Lilly USA, LLC$349
- GSK$291
- Boehringer Ingelheim$229
- plus $1K from 28 others
What the payments were for
- Food & beverage$6,055100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 115 | $2,172 |
| Novo Nordisk | 75 | $1,021 |
| Pfizer | 34 | $628 |
| Lilly USA, LLC | 21 | $349 |
| GSK | 18 | $291 |
| Boehringer Ingelheim | 15 | $229 |
| E.r. Squibb & Sons, L.L.C. | 13 | $218 |
| Merck | 7 | $140 |
| Biohaven Pharmaceuticals, Inc. | 5 | $113 |
| Philips North America LLC | 3 | $91 |
| Amgen | 5 | $87 |
| AbbVie(2 entities) | 5 | $86 |
| Kowa Pharmaceuticals America, Inc. | 6 | $81 |
| Sanofi-aventis U.S. LLC | 5 | $75 |
| Teva Pharmaceuticals USA, Inc. | 5 | $69 |
| Exact Sciences | 3 | $53 |
| Dexcom, Inc. | 2 | $38 |
| Astellas Pharma US Inc | 2 | $32 |
| Novartis | 2 | $32 |
| Radius Health, Inc. | 2 | $31 |
| Sanofi Pasteur Inc. | 2 | $25 |
| Cepheid | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Almatica Pharma LLC | 1 | $15 |
| Inspire Medical Systems, Inc. | 1 | $15 |
| Bayer | 1 | $15 |
| Bardy Diagnostics, Inc. | 1 | $15 |
| Seqirus USA Inc | 1 | $15 |
| Hologic Sales And Service, LLC | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Cranial Technologies, Inc | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
| Eisai Inc. | 1 | $13 |
| Johnson & Johnson | 1 | $11 |
How this compares
$6,055 in reported general payments places this provider in the 90th percentile of 3,945 family medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 68 | $77,248 |
| TrulicityDulaglutide | 45 | $68,882 |
| FarxigaDapagliflozin Propanediol | 54 | $60,077 |
| OzempicSemaglutide | 26 | $32,647 |
| JanuviaSitagliptin Phosphate | 27 | $32,566 |
| XareltoRivaroxaban | 18 | $27,057 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $24,795 |
| JardianceEmpagliflozin | 17 | $22,907 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $19,034 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 23 | $14,247 |
| Atorvastatin Calcium | 513 | $9,421 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 35 | $6,125 |
| Levothyroxine Sodium | 338 | $6,008 |
| Tiotropium Bromide | 11 | $5,674 |
| Omeprazole | 231 | $5,245 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $628 | $77,24868 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $2,172 | $74,32477 claims |
| Lilly USA, LLCTrulicity | $349 | $68,88245 claims |
| Novo NordiskOzempic | $1,021 | $32,64726 claims |
| MerckJanuvia | $140 | $32,56627 claims |
| Johnson & JohnsonXarelto | $11 | $27,05718 claims |
| Boehringer IngelheimJardiance | $229 | $22,90717 claims |
| GSKTrelegy Ellipta | $291 | $19,03415 claims |
| Almatica Pharma LLCSertraline Hcl | $15 | $1,947127 claims |
| AbbVieSynthroid | $86 | $1,30717 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Grand Rapids
- Rhonda MejeurGrand Rapids$493K
- Mary DagenGrand Rapids$265K
- Nirali BoraGrand Rapids$133K
- Oren MasonGrand Rapids$97K
- Magalis LlovetGrand Rapids$21K
- Derrick WilliamsonSouthfield$9.9M
- Rebecca RivardRoseville$7M
- Paul BensonBerkley$4.2M
- Michael HafranEast Lansing$2.7M
- Mitzie HewittBuckley$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.